- -

Unfolding the future of medicine through 3D deep learning technology LEARN MORE ABOUT We are delivering transformational medicines through 3D deep learning and cuttingedge drug discovery technologies. By applying revolutionary insights in 3D proteinligand cofolding we seek to target previously undruggable disease targets. MORE ABOUT US INVESTORS TECHNOLOGY Using revolutionary 3D deep learning cofolding technology combined with state of the art lab facilities we are developing a pipeline of truly novel small molecule inhibitors targeting cancers and other diseases with high unmet medical need. CHARM Therapeutics proprietary DragonFold technology inspired by the breakthroughs of our cofounder the Wiley Prize winner David Baker provides the first rapid accurate proteinligand cofolding algorithm.